Mayo Clinic Study Reveals New Drugs to Treat Hepatitis C in Post Liver Transplant Patients

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic in Florida, talks about his latest study, how two new oral medications, used post –liver transplant – are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up to one year.

Related Videos